课题基金 / 基金详情

项目摘要

项目成果

Hans Schreiber的其他基金

相似基金

相关文献

中文摘要
翻译
核心A的行政部分为Schreiber博士提供了科学领导和仔细研究的保护时间 项目规划指导。这种领导力对于实现该计划的目标至关重要 该项目依赖于整合具有高度互补但根本不同技能的科学家, 操作模式和非常多样化的方法和技术。有效的生产一体化将取决于 最大限度地减少相互作用的科学家的物理分离的负面影响。这需要 Schreiber博士专门花时间仔细规划,并长期使用轻松互动的方法 的距离.为了协调本方案项目的科学和技术活动,核心将: 组织每月一次的指导委员会会议,并与各组织领导人举行研究进展会议。 四个项目,统计员和核心主任,仔细规划议程,包括分发 (二)组织一次更全面的季度会议, 参与该计划的所有科学和技术人员,(三)准备,分发和维护电子 报告、方案和图像的档案,分发相关研究文章,㈣编写和更新 细胞系、基因构建体、单克隆抗体和载体的现有数据库,以及(v)监测每日 费用,支持和组织一名外部科学顾问和一名外部合作者的访问 每一年。核心A的统计部分为我们的统计学家Karrison博士提供了一个受保护的时间。这 为研究人员提供了一个经验丰富的学术统计学家谁是致力于成功的, 程序项目。这一安排将使我们能够更好地获得生物统计咨询, 拟议研究的规划、执行和分析阶段。A核的成像部分 P. Charles Lin博士的领导为研究人员提供了持续获得一流成像的机会, 范德比尔特研究所使用窗室技术进行光学成像。迁移和本地化 的荧光T细胞或荧光染料标记的分子,以大的良好建立的肿瘤将是 使用蔡司多光子激光通过肿瘤一侧的窗口进行监测 扫描显微镜LSM 510 Meta。新型Meta(蔡司)光谱探测器可分辨 这些不同的荧光染料有效地和准确地通过提供线性光谱解混使用专门的 软件肿瘤微环境的显微成像将为我们提供真实的 在所提出的各种模型中,时间事件和注射到小鼠中的细胞或分子的精确位置。
英文摘要
The Administrative Part of Core A provides Dr. Schreiber protected time for scientific leadership and careful guidance of the Program Project. This leadership will be essential for achieving the goals of the program project that depend on integrating scientists with highly complementary but fundamentally different skills and operation modes and very diverse methodology and technology. Effective productive integration will depend on minimizing negative effects of the physical separation of the interacting scientists. This requires dedicated time from Dr. Schreiber for careful planning and using methods of easy interaction over long distances. For coordinating the scientific and technical activities of this program project, the Core will (i) organize a monthly steering committee meeting and research-in-progress meeting with the leaders of the four projects, the statistician and the core directors with careful planning of the agenda including distribution of data, manuscripts and papers to be discussed, (ii) organizes a more comprehensive quarterly meeting of all scientific and technical personnel involved in the program, (iii) prepare, distribute and maintain electronic files of reports, protocols and images and distribute relevant research articles, (iv) prepare and update existing databases for cell lines, gene constructs, monoclonal antibodies and vectors, and (v) monitor day-today expenses, support and organize the visits of one external scientific advisor and one external collaborator per year. The Statistics Part of Core A, provides a protected time to our statistician Dr. Karrison. This provides researchers with a highly experienced scholarly statistician who is dedicated to the success of this program project. This arrangement will give us much improved access to biostatistical consultation during the planning and execution and analysis stages of the proposed studies. The Imaging Part of Core A under the leadership of Dr. P. Charles Lin provides researchers with continued access to the first rate imaging institute at Vanderbilt for optical imaging using window chamber technology. The migration and localization of the fluorescent T cells or fluorochrome-tagged molecules to large well-established tumors will be monitored through a window opening on one side of these tumors using the Zeiss multiphoton laser scanning microscope LSM 510 META. The new META (Zeiss) spectral detectors resolve emissions from these different fluorescent dyes efficiently and exactly by providing linear spectral unmixing using specialized software. The microscopic imaging of the tumor microenvironment will give us detailed information on real time events and precise locality of cells or molecules injected into mice in the various models proposed.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CD8+ T Cells and Immunological Tumor Regression
  • 批准号:
    6609963
  • 项目类别:
  • 资助金额:
    $143.89万
  • 财政年份:
    2003
  • 负责人:
    Hans Schreiber
  • 依托单位:
Three Laser BD Digital LSR
  • 批准号:
    6580559
  • 项目类别:
  • 资助金额:
    $21.0万
  • 财政年份:
    2003
  • 负责人:
    Hans Schreiber
  • 依托单位:
Administrative/Statistics/Imaging Core
  • 批准号:
    8270394
  • 项目类别:
  • 资助金额:
    $11.53万
  • 财政年份:
    2003
  • 负责人:
    Hans Schreiber
  • 依托单位:
Cancer Cells and Stroma: Eradication of Established Cancer by CD8+ T
  • 批准号:
    8375073
  • 项目类别:
  • 资助金额:
    $28.06万
  • 财政年份:
    2003
  • 负责人:
    Hans Schreiber
  • 依托单位:
国内基金
海外基金
分化肌细胞脱细胞ECM-cells sheet 3D 支架构建及其促进容积性肌组织缺损再 生修复应用及机制研究
CAFs-TAMs-tumor cells调控在HRHPV感染致癌中的作用机制研究及AI可追溯预测模型建立
  • 批准号:
    82072862
  • 项目类别:
    面上项目
  • 资助金额:
    56.0万元
  • 批准年份:
    2020
  • 负责人:
    徐云升
  • 依托单位:
S100A8/A9--Myeloid cells特异性可溶性表氧化物水解酶(sEH)基因敲除改善胰岛素抵抗的新靶点
  • 批准号:
    82070825
  • 项目类别:
    面上项目
  • 资助金额:
    53.0万元
  • 批准年份:
    2020
  • 负责人:
    徐西振
  • 依托单位:
Leader cells通过CCL5调控糖酵解及基质硬度促进结直肠癌集体侵袭的 作用机制
  • 批准号:
    81903002
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    20.5万元
  • 批准年份:
    2019
  • 负责人:
    王斐斐
  • 依托单位: